Chemosyn Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 09-07-2024
- Company Age 62 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.00 Cr
as on 09-07-2024
- Satisfied Charges ₹ 8.35 Cr
as on 09-07-2024
- Revenue -2.30%
(FY 2020)
- Profit 101.32%
(FY 2020)
- Ebitda 120.04%
(FY 2020)
- Net Worth 0.20%
(FY 2020)
- Total Assets -14.42%
(FY 2020)
About Chemosyn
The Corporate was formerly known as Chemosyn Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹8.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madhav Shah, Aanal Shah, and Kanhai Shah serve as directors at the Company.
- CIN/LLPIN
U24239MH1962PLC012310
- Company No.
012310
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Mar 1962
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Chemosyn Limited offer?
Chemosyn Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Tablets, Ayurvedic Powder and Medicinal Herbs, Medicinal Plant.
Who are the key members and board of directors at Chemosyn?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanhai Shah  | Managing Director | 13-Dec-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhav Shah | Whole-Time Director | 13-Dec-2007 | Current |
| Aanal Shah | Whole-Time Director | 18-Jul-2006 | Current |
Financial Performance and Corporate Structure Insights of Chemosyn.
Chemosyn Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 2.3% decrease. The company also saw a substantial improvement in profitability, with a 101.32% increase in profit. The company's net worth moved up by a moderate rise of 0.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemosyn?
In 2020, Chemosyn had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Op. Bank Ltd. Creation Date: 11 Feb 2010 | ₹5.00 Cr | Open |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 09 Feb 2010 | ₹15.00 Cr | Open |
Others Creation Date: 07 Dec 2016 | ₹7.00 M | Satisfied |
How Many Employees Work at Chemosyn?
Unlock and access historical data on people associated with Chemosyn, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemosyn, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemosyn's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
